Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

NCT06650488 is registered in ClinicalTrials.gov with Todd C. Lee MD MPH FIDSA as lead sponsor.

NCT NCT06650488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06650488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Lead sponsor
Todd C. Lee MD MPH FIDSA
Phase
Phase 4
Overall status
Recruiting
Start date
January 15, 2026
Completion date
January 31, 2030
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcus aureus bloodstream infection, staphylococcus aureus endocarditis, staphylococcus aureus septicemia